HinduPost is the voice of Hindus. Support us. Protect Dharma

Will you help us hit our goal?

HinduPost is the voice of Hindus. Support us. Protect Dharma
18.1 C
Varanasi
Wednesday, December 1, 2021

TAG

Bharat Biotech

Disheartening to hear some states complaining, says Bharat Biotech, after Sisodia’s accusations

Bharat Biotech has said that it is disheartening to hear some states complaining about its intentions regarding supply of its Covid-19 vaccine Covaxin. Bharat Biotech...

Bharat Biotech supplying Covaxin to 18 states

Bharat Biotech has been directly supplying its Covid-19 vaccine Covaxin to 18 states since May 1, the company said on Tuesday. "Unflinching in our efforts,...

Covid Slayer: Bharat Biotech’s BSL-3 facilities key to achieving 700M doses production

Biotechnology major Bharat Biotechs BSL-3 (Biosafety Level-3) facilities will play a pivotal role in empowering the companys plans to ramp-up production of Bharat's first...

Bharat-made vaccines land in Mexico as shots fall short in Covid war

Mexico received a consignment of 870,000 doses of the Pune-made AstraZeneca-Oxford Covid-19 vaccine from India on Sunday, the government of the Latin American country...

Bharat Biotech terms Rs 35K crore for Covid vaccine ‘far-reaching’

Covid-19 vaccine maker Bharat Biotech on Monday welcomed allocation of Rs 35,000 crore for Covid vaccination in Union Budget 2021-22, terming it a "great"...

Bharat Biotech’s Covaxin neutralizes UK variant of Covid: Study

Covaxin, the Covid vaccine developed by Bharat Biotech, effectively neutralizes UK variants of SARS-CoV-2 reducing the possibility of mutant virus escape, finds a study....

Opposition and individuals with personal biases against Modi govt are disparaging Bharat’s indigenous Covid-19 vaccines

The efforts of Bharatiya scientists who have developed the indigenous vaccines to fight the Chinese Virus are being dissed by certain sections of the...

Don’t deserve this backlash, says Covaxin maker Bharat Biotech

Bharat Biotech Chairman Krishna Ella said on Monday that the company does not deserve the backlash it is receiving in the light of the...

Latest news